论文部分内容阅读
Dear Editor,I am Dr.Daniel Russell Richardson from the West Virginia University Eye Institute in Morgantown,West Virginia,United States.I write to present a case of uveitis associated with nivolumab,which is a promising new immune checkpoint inhibitor(ICI)for metastatic melanoma and non-small cell lung carcinoma with expanding indications.As the use of nivolumab continues to increase,ophthalmologists must be aware of uveitis as an adverse event.Modulating the
Dear Editor, I am Dr. Daniel Russell Richardson from the West Virginia University Eye Institute in Morgantown, West Virginia, United States. I write to present a case of uveitis associated with nivolumab, which is a promising new immune checkpoint inhibitor (ICI) for metastatic melanoma and non-small cell lung carcinoma with expanding indications. As the use of nivolumab continues to increase, ophthalmologists must be aware of uveitis as an adverse event. Modulating the